Compare Merck & Co., Inc. (MRK) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Merck & Co., Inc. trades at $148.21 (market cap $366.28B), while Direxion Daily Semiconductor Bull 3X Shares trades at $125.61. The key difference: Merck & Co., Inc. pays a 2.29% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none, and Merck & Co., Inc. is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| MRK | SOXL | |
|---|---|---|
Market Cap | $366.28B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $156.43 | $300.77 |
52-Week Low | $77.60 | $28.60 |
Enterprise Value | $413.04B | — |
Dividend Yield | 2.29% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $148.49, down 1.23% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $156.71. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending, and maintains a robust gross profit margin of 72.97%. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting strategic growth initiatives amid a competitive pharmaceutical landscape.
The outlook for MRK is positive, driven by earnings momentum and strategic acquisitions, but risks include high valuation multiples like a P/E of 118.77 and regulatory pressures. Investors should weigh the company's solid cash flow and analyst support against potential market volatility and integration challenges from recent M&A activity.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, gained 5.19% to $123.37, reflecting strong bullish momentum in semiconductor stocks. Technical indicators show a bullish overall signal with moving averages supporting upward momentum, while oscillators remain neutral. Recent news highlights ongoing institutional interest in semiconductor ETFs despite warnings about potential short-term volatility and tariff concerns from US trade policy discussions.
The outlook for SOXL remains tied to semiconductor sector performance, with AI demand providing long-term support. However, investors face significant risks from volatility decay inherent in leveraged ETFs, potential tariff impacts, and crowded trading positioning that could trigger sharp corrections. The ETF's performance is highly correlated with major semiconductor stocks like NVIDIA.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
